Joint Corp Q4 revenue $15.2M (+3.1% YoY); FY2025 net income $2.9M; guides FY2026 system-wide sales $519-552M

JOINT Corp

Q4 revenue $15.2M (+3.1% YoY); net income from continuing ops $937K vs $909K.
FY2025 total revenue $54.9M; consolidated net income $2.9M vs net loss $5.8M in 2024.
Adjusted EBITDA from consolidated ops $13.0M (+13.9% YoY); FY2026 guidance $12.5-13.5M.
Refranchised 41 clinics in FY2025; 27 more in process; targets pure-play franchisor model.
Repurchased 1.3M shares for $11.3M in FY2025; $5.7M remaining on $12M buyback program.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

JOINT Corp reported the full year ended December 31, 2025 results: revenue $54.9 million, net income $2.9 million.

Period: the full year ended December 31, 2025
Revenue: $54.9 million
Net income: $2.9 million
Result: reported results

Exact text from the filing

Full Year Revenues of $54.9 Million, Net Income of $2.9 Million and a 13.9% Increase in Adjusted EBITDA to $13.0 Million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

JOINT Corp reported the fourth quarter ended December 31, 2025 results: revenue $15.2 million, net income $1.0 million, EPS $0.07 per diluted share.

Period: the fourth quarter ended December 31, 2025
Revenue: $15.2 million
Net income: $1.0 million
EPS: $0.07 per diluted share
Result: reported results

Exact text from the filing

Revenue increased 3.1% to $15.2 million, compared to $14.7 million in the fourth quarter of 2024.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

JOINT Corp filing history →

Source: SEC EDGAR

accession 0001612630-26-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.